Literature DB >> 18312326

Identification and characterization of 20 immunocompetent patients with simultaneous varicella zoster and herpes simplex virus infection.

K A Giehl1, E Müller-Sander, M Rottenkolber, K Degitz, M Volkenandt, C Berking.   

Abstract

BACKGROUND: It has been shown that varicella zoster virus (VZV) and herpes simplex virus (HSV) can co-localize to the same sensory ganglion. However, only a few case reports on VZV/HSV co-infections exist. Objective To identify and characterize patients with concurrent VZV and HSV infection at the same body site. SUBJECTS/
METHODS: In 1718 patients, the presence of VZV and HSV in suspicious skin lesions was investigated by polymerase chain reaction analysis. Clinical characteristics of co-infected patients were compared with matched control patients infected with either VZV or HSV. The data are discussed in the context of an extensive review of the literature.
RESULTS: Twenty (1.2%) of 1718 patients were infected with both VZV and HSV at the same body site. The mean age was 54 years (range, 2-83). The clinical diagnosis was zoster in 65%, herpes simplex in 20%, varicella in 10% and erythema multiforme in 5% of cases. The trigeminus region was affected in 60% and the trunk in 25%. Involvement of the head was most commonly associated with a severe course of disease and with older age.
CONCLUSION: Simultaneous VZV/HSV infection is rare but can occur in immunocompetent patients, which is often overlooked. The majority of cases is localized to the trigeminus region and affects elderly people.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18312326     DOI: 10.1111/j.1468-3083.2008.02587.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  Herpes zoster recurrences more frequent than previously reported.

Authors:  Barbara P Yawn; Peter C Wollan; Marge J Kurland; Jennifer L St Sauver; Patricia Saddier
Journal:  Mayo Clin Proc       Date:  2011-01-10       Impact factor: 7.616

2.  Facial Swelling and Rash Following Tooth Extraction.

Authors:  Hyungjoo Ham; Christopher E Uy; Dawn DeWitt
Journal:  J Gen Intern Med       Date:  2015-06-24       Impact factor: 5.128

3.  Varicella zoster virus latency.

Authors:  Emily Eshleman; Aamir Shahzad; Randall J Cohrs
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

4.  A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses.

Authors:  Ruth Harbecke; Michael N Oxman; Beth A Arnold; Charlotte Ip; Gary R Johnson; Myron J Levin; Lawrence D Gelb; Kenneth E Schmader; Stephen E Straus; Hui Wang; Peter F Wright; Constance T Pachucki; Anne A Gershon; Robert D Arbeit; Larry E Davis; Michael S Simberkoff; Adriana Weinberg; Heather M Williams; Carol Cheney; Luba Petrukhin; Katalin G Abraham; Alan Shaw; Susan Manoff; Joseph M Antonello; Tina Green; Yue Wang; Charles Tan; Paul M Keller
Journal:  J Med Virol       Date:  2009-07       Impact factor: 2.327

5.  Disseminated zoster in an adult patient with extensive burns: a case report.

Authors:  Yoshitaka Kubota; Kentaro Kosaka; Toshinori Hokazono; Yoshihisa Yamaji; Takafumi Tezuka; Shinsuke Akita; Motone Kuriyama; Nobuyuki Mitsukawa
Journal:  Virol J       Date:  2019-05-23       Impact factor: 4.099

6.  Simultaneous VZV and HSV-1 Reactivation after Minor Head Injury.

Authors:  Romina Häfelfinger; Anne-Valérie Burgener; Michael Osthoff; Eliska Potlukova
Journal:  Eur J Case Rep Intern Med       Date:  2020-08-21

7.  Concurrent reactivation of herpes simplex and varicella zoster viruses confirmed by the loop-mediated isothermal amplification assay.

Authors:  Tsukane Kobayashi; Akiko Yagami; Kayoko Suzuki; Tetsushi Yoshikawa; Kayoko Matsunaga
Journal:  Case Rep Dermatol       Date:  2014-01-08

8.  Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19.

Authors:  R Xu; Y Zhou; L Cai; L Wang; J Han; X Yang; J Chen; J Chen; C Ma; L Shen
Journal:  Br J Dermatol       Date:  2020-09-24       Impact factor: 11.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.